BioCentury
ARTICLE | Company News

Cambridge NeuroScience, CeNeS deal

May 30, 2000 7:00 AM UTC

CEN will acquire CNSI for $44 million consisting of 34.5 million CEN shares. CNSI shareholders will receive CEN stock equal to $2.25 per CNSI share. The new company will focus on central nervous syste...